Insulin resistance induces hyperinsulinemia and increases the level of insulin-like growth factor, which can activate the Akt/S6K/PI3K/mTOR signaling pathway in cancer (Huang et al. 2019). The gene discussed is AKT1; the disease is Hyperinsulinemia.